Akèy › Limfòm Burkitt › Idaho › Boise
Etid klinik pou Limfòm Burkitt nan Boise, ID
5 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Boise (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Saint Luke's Cancer Institute - Boise, Boise
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Ap rekriteFaz 3
- Saint Alphonsus Cancer Care Center-Boise, Boise
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Ap rekriteFaz 2
- Saint Luke's Cancer Institute - Boise, Boise
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Saint Luke's Cancer Institute - Boise, Boise
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Saint Luke's Cancer Institute - Boise, Boise
Etid Limfòm Burkitt nan lòt vil
- Houston, TX21 etid
- Milwaukee, WI16 etid
- Philadelphia, PA16 etid
- New York City, NY14 etid
- Chicago, IL14 etid
- Cincinnati, OH12 etid
- Atlanta, GA12 etid
- Seattle, WA11 etid
- Durham, NC10 etid
- Boston, MA10 etid
- Los Angeles, CA10 etid
- Aurora, CO10 etid
Lòt etid nan Boise
- Kansè Poumon ki pa ti selil14 etid
- Kansè poumon11 etid
- Kansè pwostat8 etid
- Leksemi mieloïd egi8 etid
- Kansè kolon7 etid
- Kansè nan tete6 etid
- Melanom6 etid
- Kansè kolorektal6 etid
- Sindrom detres respiratwa6 etid
- Blesi sèvo travmatik4 etid
- Sendwòm Post-Konsisyon4 etid
- Karsinòm selil skuamèz tèt ak kou4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.